ASCO 2019: Drug targeting DNA damage response shows promise against cancers of anus and genitals 01 Jun 2019 A precision medicine targeting a key protein which helps cancer cells to tolerate DNA damage has shown promising results in two clinical trials. Find out more Show/Hide
Public-private sector collaboration the theme as Minister visits The London Cancer Hub 15 Nov 2018 Business Minister Lord Henley has visited The London Cancer Hub to discuss new opportunities for life-sciences businesses to collaborate with world-leading scientists from The Institute of Cancer Research (ICR), London. Find out more Show/Hide
ICR completes new deal with company to develop ovarian cancer drug CT900 11 Oct 2018 The Institute of Cancer Research, London and global healthcare company BTG have successfully concluded negotiations with a biopharmaceutical company, Carrick Therapeutics, to take a promising precision drug discovered at The Institute of Cancer Research into a later-stage clinical trial. Find out more Show/Hide